Klick Health

Social media conversation guide

Managing Director

in
Read More

50 Questions to Get You Started in Social Media

Despite a lack of real guidance from our regulatory bodies, the pharmaceutical industry has very much awoken to the possibilities presented by social media. Most of our clients have decided not to wait for the FDA to present guidelines, working on the assumption that anything that might eventually be published will be at the highest possible level and essentially amount to new tools, old rules.

We are frequently asked to help our clients forge ahead in this brave new world, charting a course that meets their medical, regulatory, and legal requirements while taking full advantage of the bounty it has to offer. Should you find yourself on the cusp of this great adventure, this document provides a guide to the questions we typically begin with. Although fifty questions may seem overwhelming, you don’t need to answer all of them and you likely already know the answer to many. We hope that you find it useful and that it provokes some great discussions within your team and agency partners.

Get it here: Klick Pharma – Social Media Conversation Guide »

More About the Author

Jay Goldman

Jay and his team at Klick's Sensei Labs are reinventing the technology of management by helping companies execute and evolve faster with SenseiOS, the enterprise operating system for hyper-growth companies. Jay is also the co-author of the New York Times Bestseller THE DECODED COMPANY: Know Your Talent Better Than You Know Your Customers (Portfolio/Penguin), which reveals how industry-leading companies are decoding employee work data to personalize, simplify, and enhance the user experience.

More from this author

Go from news to action. Klick Wire

Weekly Digital Health Newsletter

Klick Health will NEVER spam you. Read our privacy policy

Thank you! You're now signed up to get the Klick Wire every week - news from the world of digital health marketing.

Sorry there seems to be a problem. Please try again later.